These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 33887436)

  • 1. Natural killer cells play an important role in virus infection control: Antiviral mechanism, subset expansion and clinical application.
    Zuo W; Zhao X
    Clin Immunol; 2021 Jun; 227():108727. PubMed ID: 33887436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56
    Lam JKP; Azzi T; Hui KF; Wong AMG; McHugh D; Caduff N; Chan KH; Münz C; Chiang AKS
    Front Immunol; 2020; 11():1231. PubMed ID: 32625211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutting edge: NKG2C(hi)CD57+ NK cells respond specifically to acute infection with cytomegalovirus and not Epstein-Barr virus.
    Hendricks DW; Balfour HH; Dunmire SK; Schmeling DO; Hogquist KA; Lanier LL
    J Immunol; 2014 May; 192(10):4492-6. PubMed ID: 24740502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus coinfection in children boosts cytomegalovirus-induced differentiation of natural killer cells.
    Saghafian-Hedengren S; Sohlberg E; Theorell J; Carvalho-Queiroz C; Nagy N; Persson JO; Nilsson C; Bryceson YT; Sverremark-Ekström E
    J Virol; 2013 Dec; 87(24):13446-55. PubMed ID: 24089567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of IFNγ-producing natural killer cells induced by cytomegalovirus reactivation after haploidentical hematopoietic stem cell transplantation.
    Jin F; Lin H; Gao S; Wang H; Yan H; Guo J; Hu Z; Jin C; Wang Y; Wang Z; Zhao Y; Liu Y; Zheng X; Tan Y; Li W; Dai Y; Yang Y
    Oncotarget; 2017 Jan; 8(1):51-63. PubMed ID: 27980216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.
    Lopez-Vergès S; Milush JM; Schwartz BS; Pando MJ; Jarjoura J; York VA; Houchins JP; Miller S; Kang SM; Norris PJ; Nixon DF; Lanier LL
    Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14725-32. PubMed ID: 21825173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKG2C(+)CD57(+) Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8(+) T Cell Evolution towards Senescence.
    Heath J; Newhook N; Comeau E; Gallant M; Fudge N; Grant M
    J Immunol Res; 2016; 2016():7470124. PubMed ID: 27314055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of killer cell immunoglobulin-like receptors (KIRs) by natural killer cells during acute CMV infection after kidney transplantation.
    de Rham C; Hadaya K; Bandelier C; Ferrari-Lacraz S; Villard J
    Transpl Immunol; 2014 Sep; 31(3):157-64. PubMed ID: 25158213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subordinate Effect of -21M HLA-B Dimorphism on NK Cell Repertoire Diversity and Function in HIV-1 Infected Individuals of African Origin.
    Cubero EM; Ogbe A; Pedroza-Pacheco I; Cohen MS; Haynes BF; Borrow P; Peppa D
    Front Immunol; 2020; 11():156. PubMed ID: 32132995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus-specific peptide dependent NK cell cytotoxicity.
    Tong L; Assenmacher M; Zänker KS; Jähn P
    Inflamm Allergy Drug Targets; 2014; 13(2):128-33. PubMed ID: 24517290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of immunoglobulins and natural killer cells in the context of CMV and EBV infection.
    Frenzel K; Lehmann J; Krüger DH; Martin-Parras L; Uharek L; Hofmann J
    Med Microbiol Immunol; 2014 Apr; 203(2):115-23. PubMed ID: 24337366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late Development of FcεRγ
    Muccio L; Falco M; Bertaina A; Locatelli F; Frassoni F; Sivori S; Moretta L; Moretta A; Della Chiesa M
    Front Immunol; 2018; 9():1050. PubMed ID: 29868012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Signatures of Natural Killer Cells in CMV-Associated Anterior Uveitis, A New Type of CMV-Induced Disease in Immunocompetent Individuals.
    Yawata N; Shirane M; Woon K; Lim X; Tanaka H; Kawano YI; Yawata M; Chee SP; Siak J; Sonoda KH
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural Killer Cells Adapt to Cytomegalovirus Along a Functionally Static Phenotypic Spectrum in Human Immunodeficiency Virus Infection.
    Holder KA; Lajoie J; Grant MD
    Front Immunol; 2018; 9():2494. PubMed ID: 30483249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus-Driven Adaption of Natural Killer Cells in NKG2C
    Comeau EM; Holder KA; Fudge NJ; Grant MD
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30857329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Natural Killer Cells in HIV Patients Beginning Therapy with a High Burden of Cytomegalovirus.
    Ariyanto IA; Estiasari R; Edwar L; Makwana N; Lee S; Price P
    Immunol Invest; 2019 May; 48(4):345-354. PubMed ID: 30422022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood.
    Della Chiesa M; Falco M; Bertaina A; Muccio L; Alicata C; Frassoni F; Locatelli F; Moretta L; Moretta A
    J Immunol; 2014 Feb; 192(4):1471-9. PubMed ID: 24442432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2.
    Saini P; Adeniji OS; Bordoloi D; Kinslow J; Martinson J; Parent DM; Hong KY; Koshy J; Kulkarni AJ; Zilberstein NF; Balk RA; Moy JN; Giron LB; Tracy RP; Keshavarzian A; Muthumani K; Landay A; Weiner DB; Abdel-Mohsen M
    mBio; 2023 Feb; 14(1):e0339322. PubMed ID: 36728420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the natural killer cell KIR repertoire by cytomegalovirus infection.
    Charoudeh HN; Terszowski G; Czaja K; Gonzalez A; Schmitter K; Stern M
    Eur J Immunol; 2013 Feb; 43(2):480-7. PubMed ID: 23161492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Epstein-Barr Virus Oncogene EBNA1 Suppresses Natural Killer Cell Responses and Apoptosis Early after Infection of Peripheral B Cells.
    Westhoff Smith D; Chakravorty A; Hayes M; Hammerschmidt W; Sugden B
    mBio; 2021 Dec; 12(6):e0224321. PubMed ID: 34781735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.